MICHAEL TRIMBLE: Open Payments
NPI 1770859639 · MOUNT JULIET, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 35 payments from 13 companies in 2025. Trend: 2023 $33 · 2024 $80 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| Novo Nordisk Inc | 4 | $88 |
| Corcept Therapeutics | 4 | $86 |
| Lilly USA, LLC | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| ABBVIE INC. | 3 | $57 |
| Amgen Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Astellas Pharma US Inc | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: Korlym, CAPLYTA, Rybelsus, FARXIGA, OTEZLA, SHINGRIX, QULIPTA, BREZTRI.
Industry payments across TN — which companies pay providers there.
